Gordius (Gabapentin)

Gordius (gabapentin) is prescribed for several neurological and pain‑related conditions that are approved for use in the European Union.

• Adjunctive therapy for focal (partial) seizures in epilepsy.
• Management of neuropathic pain associated with diabetic peripheral neuropathy.
• Treatment of postherpetic neuralgia to reduce pain after shingles.
• Relief of symptoms in restless legs syndrome.
• Off‑label use for certain anxiety disorders under specialist supervision.

Side effects of gabapentin may vary in frequency and severity, and they are typically reported by patients taking Gordius.

Common

• Dizziness
• Fatigue
• Somnolence
• Peripheral edema

Serious

• Severe allergic reactions such as Stevens‑Johnson syndrome
• Suicidal thoughts or behavior
• Respiratory depression, especially when combined with other depressants

Before starting Gordius, clinicians should evaluate several safety considerations to minimize risks.

• Adjust dose in patients with renal impairment.
• Pregnancy and breastfeeding status are unknown; use only if benefits outweigh risks.
• Monitor for mood changes or suicidal ideation.
• Review history of psychiatric disorders before initiation.
• Avoid abrupt discontinuation to reduce seizure recurrence.
• Use lower initial doses in elderly patients due to increased sensitivity.

Gabapentin can interact with other medicines, and some combinations should be avoided while others require careful monitoring.

Avoid

• Antacids containing aluminum or magnesium, which can reduce gabapentin absorption.
• Opioid analgesics, because combined use may increase central nervous system depression.
• Alcohol, due to additive sedative effects.

Use with caution

• Other central nervous system depressants such as benzodiazepines or barbiturates.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) in patients with renal dysfunction.
• ACE inhibitors or angiotensin receptor blockers, which may affect renal clearance.
• Loop or thiazide diuretics, as they can alter gabapentin excretion.